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C
arol Dieckmann says she always 
wanted to be a scientist. As a kid, 
her friends called her “Nature 
Lady,” and she loved exploring tide pools 
with neighborhood friends in San Diego. 
But the world of science really opened up 
to her once she discovered the microscopic 
world and molecular biology. From then 
on, nothing could hold her back.
Dieckmann published her fi  rst paper 
as an undergraduate at UC Irvine in Cali-
fornia. This taste of success in the lab 
was tantalizing and propelled her into 
graduate school at UC San Diego and a 
postdoc at Columbia University. In New 
York, she encountered the two problems 
that would preoccupy her throughout the 
rest of her career: regulation of mito-
chondrial gene expression (1–3) and the 
assembly of the eyespot (4–6)—the 
light-sensing organelle of the alga Chlamy-
domonas. We called her at her lab at the 
University of Arizona to discuss what 
drew her out of California and into the 
study of these two subjects.
REGULATORY SWITCHES
One of the two subjects your lab works 
on is mitochondrial biology…
I fi  rst started working on this as a post-
doc in Alexander Tzagoloff’s lab. When 
I joined Alex’s lab, I 
wanted to study how 
nuclear gene products 
regulate mitochondrial 
genes. We knew it was 
pretty much a one-way 
street and that there 
would be proteins en-
coded in the nucleus that 
would be translated in 
the cytoplasm and then 
imported into mitochondria to regulate 
mitochondrial gene expression.
Alex had already started making this 
huge collection of nuclear mutants that af-
fected respiration, and we decided that I 
would survey this collection for mutants 
that affected cytochrome b, which is the 
only mitochondrially encoded subunit of 
the CoQ–cytochrome c reductase complex. 
My naïve thought was that we would fi  nd 
transcriptional regulators.
At the time, most of the regulation we 
knew about in the nuclear genome was at 
the transcriptional level. But over the last 30 
years the general picture that has emerged 
is that there is very little transcriptional 
regulation in mitochondria. Most of the 
regulation of gene expression occurs post-
transcriptionally, at the level of RNA stabil-
ity, processing, and translation, and so what 
I ended up working on were proteins that 
regulate mitochondrial messenger RNAs.
What part of this problem are you 
working on now? 
The interesting thing is that there are only 
seven messenger RNAs that are made 
from the yeast mitochondrial genome. 
Each one of them is affected by a different 
set of proteins that regulates its stability 
and translation.
These mRNAs have to be processed out 
of longer transcripts, some of which also 
encode tRNAs, two ribosomal RNAs, and 
a small RNA that is part of an enzyme 
called RNase P. The activity of this enzyme 
is to cleave the 5 presequences off of 
tRNA precursors. Several years ago we 
made the observation that mutations in 
the genes that code for 
enzymes in the mito-
chondrial fatty acid bio-
synthetic pathway (and 
an extension of that path-
way that makes lipoic 
acid) are defective in 
processing tRNAs. Our 
hypothesis is that the 
protein subunit of mito-
chondrial RNase P is 
modifi  ed by a fatty acid that’s made from 
this pathway inside the mitochondria. We 
have identifi  ed which residue we think is 
modifi  ed, and we’re looking into why this 
fatty acid modifi  cation is necessary.
From a regulatory point of view, it’s 
interesting that fatty acid synthesis and 
tRNA processing should be linked. In all 
organisms, lipoic acid is attached to 
pyruvate dehydrogenase, the enzyme 
that converts pyruvate to acetyl CoA. 
Acetyl CoA in turn is a precursor for 
fatty acids and lipoic acid, so it’s a posi-
tive feedback cycle. Positive feedback 
tends to make changes in metabolism 
more switch-like instead of oscillatory, 
so the idea is that, in yeast, if you’re fer-
menting and then you want to switch to 
respiration, this may allow you to quickly 
ramp up respiration. At the same time, 
you’d also be making a fatty acid that 
affects tRNA processing, which would 
affect gene expression and possibly assist 
in the switch.
EYEING NEW PROSPECTS
How did you start working on the 
Chlamydomonas eyespot?
When I fi  rst went to New York as a post-
doc, I regularly went to the New York 
area yeast group meeting. One of the peo-
ple that I met there was Susan Dutcher, 
who was studying flagellar function in 
Chlamydomonas. She came to the yeast 
group meeting because she’d done her 
graduate work in yeast and wanted to 
stay up to date. She heard me give a talk 
one night and came up afterwards and told 
me she thought I’d be really interested 
in this organelle in Chlamydomonas called 
the eyespot. I said, “Oh? Why is that?” 
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Carol Dieckmann studies the Chlamydomonas eyespot and mitochondrial gene expression.
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and she told me that components in the 
cell membrane and the chloroplast col-
laborate to make the eye. I thought that 
was very cool, but at the time it wasn’t 
possible to transform Chlamydomonas. I 
promised I’d come back and work on it if 
they ever fi  gured out how to do that. As it 
turned out, that didn’t happen until after 
I got my faculty position here at Arizona. 
But then I was able to take a sabbatical 
and visit Susan’s lab to get started on it.
We’ve come a long way in our analysis 
of the eyespot. One of the really interest-
ing problems is that in general this single-
celled organism has bilateral symmetry, 
except that it only has one eye and it’s 
placed asymmetrically relative to all the 
other symmetric elements in the cell. I be-
came fascinated with the whole problem 
of how the eyespot gets placed. The other 
problem we’ve been pursuing concerns 
how the eyespot is assembled.
Our best hypothesis right now is that 
the eyespot’s location is specifi  ed by a 
microtubule-based system. Just below 
the fl  agellar basal bodies are four micro-
tubule rootlets, and the eyespot is always 
associated with one specifi  c rootlet. We 
think that the photoreceptor rhodopsin, 
which is found in the cell membrane in 
the eyespot, traffi  cs from the Golgi to the 
eyespot along this rootlet and is anchored 
there by a protein in the chloroplast 
membrane called EYE2. After that, pig-
ment granules—they’re what make the 
eyespot orange—get recruited beneath 
the chloroplast membrane.
A DIFFERENT VISTA
What did you work on before your 
postdoc?
I did my graduate work in Stuart Brody’s 
lab at the University of California, San 
Diego. I worked on something completely 
different: circadian rhythmicity in a fun-
gus called Neurospora. I was particularly 
interested in a set of mutants that were 
defective in the mitochondrial enzyme 
ATP synthase. They are defective in keep-
ing time; their “clock” runs faster than 
that in wild-type strains.
So you switched organisms but not 
organelles for your postdoctoral work?
I was really interested in trying to use 
molecular biology to study protein im-
port into mitochondria, but back then 
nobody was transforming anything but 
bacteria, and they’d only been doing that 
for a few years. I knew I couldn’t do it 
in  Neurospora yet because the tools 
hadn’t been developed.
Jerry Fink was in San Diego for a day 
or two to give a seminar. I requested to 
meet with him and asked 
him for suggestions about 
where I could go to learn 
how to do transformations. 
He said, “Well, in a couple 
years, everybody’s going 
to be transforming yeast. 
You should really go work 
with somebody who knows 
about yeast mitochondria.” 
I hadn’t thought about that, so I asked 
him for suggestions on good labs and he 
suggested Alex Tzagoloff in New York. I 
just laughed because, when all my friends 
had asked me where I wanted to go for 
my postdoc, I’d said, “I’ll go anywhere 
except New York City.”
Why didn’t you want to go to New York?
Well, I had grown up primarily in San 
Diego. I was a Southern California 
beach girl—I lived right by the ocean, 
and we spent a lot of time at the beach 
and in the water, sailing and body surf-
ing. I just thought that I wouldn’t survive 
in New York without all that. But I did, 
and actually I had a wonderful time in 
New York. Also, after about a year I dis-
covered that the cultural advantages far 
outweighed the negatives. I really enjoy 
dance, and it’s a wonderful place to be 
for that. And food—the restaurants there 
are great, better than in Tucson!
There aren’t any beaches in Arizona, 
either…
Fortunately I love the desert, too. I grew 
up not too far from the Southern Califor-
nia desert, out in Borrego, 
and this area is lush in 
comparison because we get 
a lot of summer rain. We 
have a lot of huge cacti, 
and the plant life and ani-
mal life are pretty amazing 
out in the wild areas. Any-
body who is interested in 
nature should really visit 
Tucson. And I still get to swim—I just 
have to do it in a pool.
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Green algae growing in a Tucson pond. 
Chlamydomonas (inset) is found in freshwater 
environments worldwide.
Chlamydomonas labeled with antibodies to 
rhodopsin (red), EYE2 (green), and acetylated 
microtubules (blue).
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“We’ve come 
a long way in 
our analysis 
of the 
eyespot.”